Clinical Trials
21 trialsLIVERAL
ANRS, Emerging Infectious Diseases
LHWAA
Thomas Jefferson University
YIV-906 (Formerly PHY906/KD018) With Sorafenib in HBV(+) Hepatocellular Carcinoma (HCC)
Yiviva Inc.
OUTREACH2
Mina Alpha Limited
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Nurse-led Decision Counseling on Hepatocellular Carcinoma Screening
Chinese University of Hong Kong
Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
National Institute of Allergy and Infectious Diseases (NIAID)
Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)
GlaxoSmithKline
Comparison of Prophylactic Antiviral Efficacy in Patients Undergoing Chemotherapy: Entecavir Versus Lamivudine
Seoul National University Hospital
Community-based Hepatitis B Interventions for Hmong Adults
University of California, Davis
Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)
Merck Sharp & Dohme LLC
OPTISCREEN-B
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
OPTISCREEN-III
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Increasing Hepatitis B Screening Among Korean Church Attendees
University of California, Los Angeles
Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer
Eastern Hepatobiliary Surgery Hospital
TACEPVE
Eastern Hepatobiliary Surgery Hospital
A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers
Hospital Authority, Hong Kong
HBVNHL
Taipei Veterans General Hospital, Taiwan
Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital
Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C Infection
The 108 Military Central Hospital
Qidong Hepatitis B Intervention Study
University of Oxford